A decisive step in the evaluation of biocompatibility
In the Medical Products Industry, product safety is not limited to mechanical performance or sterilization processes. The assessment of the biological safety of all medical devices that come into contact with the human body is of great importance. In this context, one of the most basic biocompatibility tests is the "in vitro cytotoxicity test".
Especially since the European Union Medical Devices Regulation came into force (MDR 2017/745), biocompatibility assessments for manufacturers have gained considerably in importance. In vitro cytotoxicity tests are performed to determine whether the product exerts a toxic effect on cells.
What is an in vitro cytotoxicity test?
The in vitro cytotoxicity test is a laboratory analysis that evaluates the potential toxic effects of a medical device or product material on cell cultures.
This test examines the following parameters:
- Cell viability,
- Cell growth,
- Cell morphology,
- Cell damage
The aim is to identify possible damage caused by chemical components that can be released from the product to biological systems at an early stage.
The importance of the ISO 10993-5 standard
In vitro cytotoxicity tests are usually conducted in accordance with the ISO 10993-5 standard published by the International Organization for Standardization.
This standard defines:
- Test procedures,
- Requirements for cell culture,
- Evaluation criteria,
- Methods for interpreting the results
The ISO 10993 series is one of the world-renowned basic references for assessing the biocompatibility of medical devices.
What medical devices are they required for?
The cytotoxicity test is required for many products that come into direct or indirect contact with the human body.
Examples:
- Surgical Implants
- Catheter
- Injection systems
- Wound dressings
- Dental Materials
- Medical hoses
- Single-use medical devices
must be evaluated in terms of their biocompatibility in the product development process.
Test methods used
Various cytotoxicity methods can be used within the framework of ISO 10993-5.
Extraction Method: The material of the product is extracted with suitable solvents and the extract obtained is applied to a cell culture.
Direct contact method: The sample is directly contacted with the cell surface.
Agar diffusion method: The spread of the toxic effect is evaluated using an agar layer between the sample and the cells.
The test method is determined depending on the product type, purpose and material composition.
Parameters rated in cytotoxicity tests
Various biological parameters are examined in the laboratory analyzes:
- Cell viability rate
- Cell proliferation
- Morphological Changes
- Membrane damage
- Metabolic Activity
Based on these reviews, it is determined whether the product is safe at the cellular level.
The role of cytotoxicity tests in the MDR process
With the European Union's MDR regulation, the importance of biocompatibility dossiers in technical documentation has increased.
Manufacturers are expected to provide product safety by:
- Risk analysis,
- clinical reviews,
- chemical characterization studies,
- Biocompatibility Test Reports
prove.
Therefore, cytotoxicity tests are no longer just a laboratory analysis, but have become one of the basic components of compliance with the regulations.
Benefits of in vitro testing
Compared to conventional in vivo methods, in vitro tests offer numerous advantages:
- Faster results
- Lower costs
- Ethically advantageous approach
- High reproducibility
- Standardized Analysis Methods
In particular, with the increasing spread of alternative test methods, in-vitro analyses are gaining in importance in the medical device industry.